L

Lord Cryer (Lab)

Speaking in the House of Lords on 18 November 2024

Debate

NHS: Anti-obesity Medication

Contribution

I appreciate what the noble Lord says but, again, the processes that lead to drugs becoming available on the NHS are extremely rigorous. The noble Lord seemed to imply, or he said, that the processes that lead to drugs becoming available on the NHS were somehow curtailed or somehow short. They are not. They go on for a very long time. The latest obesity drug has been going through those processes for many months and is still not available. It might be available in the very near future, but it is not available at the moment because it is going through such a rigorous process.

More from Lord Cryer (Lab)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.

Partner sites